基于UPLC-Q-TOF-MSn的化妆品中40种性激素非法添加分析方法及筛查数据库的建立

目的 建立基于UPLC-Q-TOF-MSⁿ的化妆品中40种性激素非法添加分析方法及筛查数据库。方法 色谱柱为Agilent SB-C₁₈(2.1 mm×50 mm，1.8 μm)，正离子模式以0.1%甲酸水溶液-乙腈为流动相，负离子模式以水-乙腈为流动相，梯度洗脱，流速0.2 mL·min^-1，柱温35 ℃；采用电喷雾电离源(ESI)，采集模式为Scan MS及Targeted MS/MS，将40种性激素的精确质量数、保留时间、二级质谱图导入PCDL软件建立筛查数据库。结果 采用所建立的数据库方法快速筛查100批化妆品，1批育发类产品检出少量黄体酮。结论 本研究所建立的40种性激素分析方法和筛查数据库具有简便、快速、灵敏和准确的特点，适合化妆品中非法添加性激素的高通量筛查和准确定性。     

An international pilot study of an internet‐based platform to facilitate clinical research in epilepsy: The EpiNet project

Purpose: We created an epilepsy patient database that can be accessed via the Internet by neurologists from anywhere in the world. The database was designed to enroll and follow large cohorts of patients with specific epilepsy syndromes, and to facilitate recruitment of patients for investigator‐initiated clinical trials. Methods: The EpiNet database records physician‐derived information regarding seizure type and frequency, epilepsy syndrome, etiology, drug history, and investigations. It can be accessed from any country by approved investigators via a secure, password‐protected Website. All data are encrypted. The database is for both research and clinical purposes. Investigators were invited to register any patient with epilepsy, but were particularly encouraged to register patients when uncertain of the optimal management. Participation required approval from investigators’ ethics committees and institutional review boards, and all patients or their caregiver provided written informed consent. Patients were not enrolled in clinical trials in this pilot study. Key Findings: The international pilot study recruited patients from September 2010 to November 2011. Sixty‐four investigators or research assistants from 25 centers in 13 countries registered 1,050 patients. Patients with a wide range of epilepsy syndromes and etiologies were registered. Patients’ ages ranged from 2 weeks to 90 years. Significance: The Website was successfully used by doctors working in different health systems. The pilot study confirmed that this low‐cost, collaborative approach to research has great potential. Large, multicenter cohort studies will commence in 2012, and randomized clinical trials are being planned. All epileptologists are invited to join this project.     

LIS系统与东方旗云软件联合用于细菌耐药性统计优势

目的寻找准确、便捷的细菌耐药性统计系统。方法通过东方旗云软件与实验室细菌鉴定仪的连接，将细菌药敏结果直接导如whonet系统。结果可以准确、简便、快捷的统计细菌耐药性，以便监测细菌耐药趋势，合理指导临床用药。结论东方旗云软件可LIS系统联合在实验室信息系统管理与细菌耐药性统计方面有重要实用价值。     

全国恶性肿瘤介入治疗数据库及登记系统设计初探

目的本课题是十一五国家科技支撑计划课题常见恶性肿瘤介入治疗方法规范化的比较研究和中远期疗效评估的一个子课题,根据计划书需要采用国际标准化的登记方法,建立全国恶性肿瘤介入治疗登记系统,整合多中心的病历资料,构建肿瘤介入治疗数据库。方法采用软件下载、自主管理、自动整合的技术方案,实现全国恶性肿瘤介入治疗数据库及登记系统的建立。结果建立完成全国肿瘤介入治疗数据库及登记系统,实现肿瘤介入治疗的信息化管理,可以进行数据的简单或复合查询,在院内调试及初运行良好。结论全国恶性肿瘤介入治疗数据库及登记系统的建立,不仅可以明确肿瘤介入治疗的全国普及率,不同肿瘤介入治疗的疗效,最新介入手段应用情况,便于不同医院之间的技术交流,提高介入医师诊治水平,而且能了解介入人才的分布结构,介入器材的消耗品种及数量,优化资金,节约医疗成本。     

Validation of SmartRank: A likelihood ratio software for searching national DNA databases with complex DNA profiles

Searching a national DNA database with complex and incomplete profiles usually yields very large numbers of possible matches that can present many candidate suspects to be further investigated by the forensic scientist and/or police. Current practice in most forensic laboratories consists of ordering these ‘hits’ based on the number of matching alleles with the searched profile. Thus, candidate profiles that share the same number of matching alleles are not differentiated and due to the lack of other ranking criteria for the candidate list it may be difficult to discern a true match from the false positives or notice that all candidates are in fact false positives. SmartRank was developed to put forward only relevant candidates and rank them accordingly. The SmartRank software computes a likelihood ratio (LR) for the searched profile and each profile in the DNA database and ranks database entries above a defined LR threshold according to the calculated LR. In this study, we examined for mixed DNA profiles of variable complexity whether the true donors are retrieved, what the number of false positives above an LR threshold is and the ranking position of the true donors. Using 343 mixed DNA profiles over 750 SmartRank searches were performed. In addition, the performance of SmartRank and CODIS were compared regarding DNA database searches and SmartRank was found complementary to CODIS. We also describe the applicable domain of SmartRank and provide guidelines. The SmartRank software is open-source and freely available. Using the best practice guidelines, SmartRank enables obtaining investigative leads in criminal cases lacking a suspect.